Range
28.17 - 28.89
Vol / Avg.
11.3K/248.1K
Div / Yield
-
52 Wk
22.1 - 41.16
Mkt Cap
979.7M
Payout Ratio
-
Open
28.31
P/E
-
EPS
-0.86
Shares
34.8M
Outstanding
34.8M
Total Float
22M
load more
Sector: Health Care.Industry: Biotechnology
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKROAkero Therapeutics-0.64%979.7M

Akero Therapeutics Frequently Asked Questions

Q

How do I buy Akero Therapeutics (AKRO) stock?

A

You can purchase shares of Akero Therapeutics (NASDAQ: AKRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akero Therapeutics's (AKRO) competitors?

Q

What is the target price for Akero Therapeutics (AKRO) stock?

A

The latest price target for Akero Therapeutics (NASDAQ: AKRO) was reported by Morgan Stanley on March 23, 2021. The analyst firm set a price target for 63.00 expecting AKRO to rise to within 12 months (a possible 123.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Akero Therapeutics (AKRO)?

A

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $28.13 last updated Today at 2:08:53 PM.

Q

Does Akero Therapeutics (AKRO) pay a dividend?

A

There are no upcoming dividends for Akero Therapeutics.

Q

When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?

A

Akero Therapeutics does not have any upcoming earnings scheduled.

Q

Is Akero Therapeutics (AKRO) going to split?

A

There is no upcoming split for Akero Therapeutics.

Q

What sector and industry does Akero Therapeutics (AKRO) operate in?

A

Akero Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.